Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

511 - 520 of 871 results found

Off-Label Use of Baricitinib in Dermatology

Date
Wednesday, August 09, 2023 - 4:00 AM
Description
The current US Food and Drug Administration (FDA) indications for baricitinib include alopecia areata, rheumatoid arthritis, and COVID-19. However, increasing evidence indicates that baricitinib is effective in treating a variety of dermatological

Otolaryngologic Side Effects After COVID-19 Vaccination

Date
Friday, August 04, 2023 - 4:00 AM
Description
CONCLUSIONS: Although several otolaryngologic symptoms were reported, few were found to be clinically significant. Of note, facial paralysis, Bell's palsy, and anaphylaxis did not meet signal thresholds to be determined significant.